
SynthioLabs is a life sciences company that provides an AI-powered platform for pharmaceutical go-to-market teams. Their core product, Nexa, acts as an AI Medical Expert, enabling compliant, credible, and science-first engagement with physicians. Nexa aims to increase HCP reach by 3x, offering features like physician identification, compliant discussions, and appointment booking. The platform also emphasizes safety and trust with bias mitigation, pre-approved content, embedded security, and auditable logs. SynthioLabs' platform supports various use cases including medical information automation, patient support, and HCP engagement, making teams up to 10x more productive by assisting with pre-call preparation and CRM note automation. The company was founded by ex-McKinsey and ex-ZS Life Sciences experts, along with AI Researchers from AWS, who have extensive experience with top pharma companies.

SynthioLabs is a life sciences company that provides an AI-powered platform for pharmaceutical go-to-market teams. Their core product, Nexa, acts as an AI Medical Expert, enabling compliant, credible, and science-first engagement with physicians. Nexa aims to increase HCP reach by 3x, offering features like physician identification, compliant discussions, and appointment booking. The platform also emphasizes safety and trust with bias mitigation, pre-approved content, embedded security, and auditable logs. SynthioLabs' platform supports various use cases including medical information automation, patient support, and HCP engagement, making teams up to 10x more productive by assisting with pre-call preparation and CRM note automation. The company was founded by ex-McKinsey and ex-ZS Life Sciences experts, along with AI Researchers from AWS, who have extensive experience with top pharma companies.
Headquarters: San Francisco, California
Core product: Nexa (AI Medical Expert) and clinical-grade voice/multimodal AI suite (Jarvis, Ather, Helix, Simulation Studio)
Use cases: HCP engagement, medical information automation, patient support, simulation/insights
Seed funding: $5M seed led by Elevation Capital (investors include 1984 Ventures, Peak XV Partners, Y Combinator, Pioneer Fund)
Founded: 2024
Improving reach, compliance, and productivity of pharmaceutical go-to-market and medical affairs teams through AI-powered engagement and automation.
2024
Biotechnology
$5,000,000
Company blog announcement of $5M seed; participation from 1984 Ventures, Peak XV Partners, Y Combinator, and strategic angels
Crunchbase lists a Seed round announced June 4, 2025 and shows Pioneer Fund as an investor
“Participation from institutional investors and accelerator (Elevation Capital lead, 1984 Ventures, Peak XV Partners, Y Combinator, Pioneer Fund) indicating VC and accelerator backing”